Læknablaðið - 15.09.1994, Blaðsíða 15

LÆKNABLAÐIÐ 1994; 80
291
22. European Fraxiparin Study Group. Comparison of a low
molecular weight heparin and unfractionated heparin in
the prevention of deep vein thrombosis in patients un-
dergoing abdominal surgery. Br J Surg 1988; 75: 1058-
63.
23. Dahan M, Levaiseur Ph, Bogaty J. Bonev B, Samama
M. Prevention of postoperative deep vein thrombosis
(DVT) in malignant patients by fraxiparine. A cooper-
ative trial. Thromb Haemost 1989; 62: 519a.
24. Bergqvist D, Burmark US, Frisell J, et al. Low molec-
ular weight heparin onece daily compared with conven-
tional low-dose heparin twice daily. A prospective dou-
ble-blind multicentre trial on prevention of postoper-
ative thrombosis. Br J Surg 1986; 73: 204-8.
25. Bergqvist D, Matsch T. Burmark US, et al. Low molec-
ular heparin given the evening before surgery compared
with conventional heparin in prevention of thrombosis.
Br J Surg 1988; 75: 888-91.
26. Fricker J-P. Vergens Y, Schach R et al. Low dose hepa-
rin versus low molecular weight heparin (Kabi 2165,
Fragmin) in the prophylaxis of thromboembolic compli-
cations of abdominal oncological surgery. Eur J Clin
Invest 1988; 18: 561-7.
27. Onarheim H, Lund T. Heimdal A, Arnesjö B. A low
molecular weight heparin (Kabi 2165) for prophylaxis of
postoperative deep vein thrombosis. Acta Chir Scand
1986; 186: 593-6.
28. Boiessel J (Post-surgery Logiparin Study Group). Com-
parison of two doses of low molecular weight heparin
and standard heparin in prevention of postoperative
DVT. Thromb Haemost 1989; 62: 523.
29. Leizorovicz 91, Picolet H. Peyrieux JC, Boiessel JP and
the HBOM Research Group. Prevention of perioper-
ative deep vein thrombosis in general surgery: A multi-
centre double blind study comparing two doses of Logi-
parin and standard heparin. Br J Surg 1991; 78: 412-6.
30. Samama M, Bernard P. Bonnardot JP, et al. Low mole-
cular weight heparin compared with unfractionated he-
parin in prevention of postoperative thrombosis. Br J
Surg 1988; 75: 128-31.
31. Clagett GP. Reisch JS. Prevention of venous throm-
boembolism in general surgical patients. Result of meta-
analysis. Ann Surg 1988; 208: 227-40.
32. Hoek J, Nurmohamed MT, tenCate JW. Biiller HR.
Prevention of deep vein thrombosis (DVT) following
total hip replacement by a low molecular weight hepari-
noid (ORG 10172). Thromb Haemost 1989; 62: 520a.
33. Lassen MR, Borris LC, Christiansen HM, et al. Preven-
tion of thromboembolism in 190 hip arthroplasties.
Comparison of LMW heparin and placebo. Acta Orthop
Scand 1991; 62: 33-8.
34. Dechavenne M, Velle D, Berruyer M, et al. Rando-
mized trial of a low molecular weight heparin (Kabi
2165) versus adjusted subcutaneous standard heparin in
the prophylaxis of deep vein thrombosis after elective
hip surgery. Haemostasis 1989; 1: 5-12.
35. Eriksson BI. Eriksson E, Wadenvik H, Tengborn L,
Risberg B. Comparison of low molecular weight heparin
and unfractionated heparin in prophylaxis of deep vein
thrombosis and pulmonary embolism. Thromb Haemos-
tas 1989; 62: 470a.
36. Planes A, Vochelle N, Mazas F, et al. Prevention of
postoperative venous thrombosis: A randomized trial
comparing unfractionated heparin with low molecular
weight heparin in patients undergoing total hip replace-
ment. Thromb Haemost 1988; 60: 407-10.
37. Turpie AGG, Levine MN, Hish J. A randomized con-
trolled trial of a low molecular-weight heparin (Enoxa-
parin) to prevent deep-vein thrombosis in patients un-
dergoing elective hip surgery. N Eng J Med 1986; 315:
925-9.
38. DESG (Danish Enoxaparin Study Group). Low mole-
cular weight heparin (enoxaparin) vs Dextran 70. Arch
Intern Med 1991; 151: 1621-4.
39. Levine MN, Hirsh J, Gent M, et al. Prevention of deep
vein thrombosis after elective hip surgery. A rando-
mized trial comparing low molecular weight heparin
with standard unfractionated heparin. Ann Intern Med
1991; 114: 545-51.
40. Francis CW, MarderVJ, McCollisterE, Yaukoolbodi S.
Two-step warfarin therapy. Prevention of postoperative
venous thrombosis without excessive beeding. JAMA
1983; 249: 374-8.
41. Powers PJ, Gent M, Jay, RM, et al. A randomized trial
of less intense postoperative warfarin or aspirin therapy
in the prevention of venous thromboembolism after sur-
gery for fractured hip. Arch Intern Med 198; 149:
42. Francis CW, Pellegrini VD, Marder VJ, et al. Anti-
thrombin III/Iow dose heparin in comparison with dex-
tran 40 in prevention of venous thrombosis following
total hip arthroplasty. J Bone Joint Surg (Am) 1989; 71:
327-35.
43. Nurmohammed MT, Rosendaal FR, Biiller HR, et al.
Low-molecular-weight heparin versus standard heparin
in general and orthopaedic surgery: a meta-analysis.
Lancet 1992; 340: 152-6.
44. Thomas DP. Prevention of post-operative thrombosis
by low molecular weight heparin in patients undergoing
hip replacement. Thromb Haemost 1992; 67: 491-3.
45. Bergqvist D. Review of clinical trials of low molecular
weight heparins. Eur J Surg 1992; 158: 67-78.
46. Kakkar VV, Cohen AT, Edmonson RA, et al. Low
molecular weight versus standard heparin for prevention
of venous thromboembolism after major abdominal sur-
gery. Lancet 1993; 347: 259-65.
47. Önundarson PT. Blóðflögufæð og segamyndun heparíns
(Heparin induced thrombocytopenia and thrombosis).
Læknablaðið 1991; 77: 277-84.
48. Hirsh J, Levine MN. Low molecular weight heparin
(Review article). Blood 1992; 79: 1-17.